The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.
Campion
G V
GV
Synergen Europe Inc, The Hague, The Netherlands.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D016207:Cytokines / Q000037:antagonists & inhibitors*; D006801:Humans; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D008264:Macrophages / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D016207:Cytokines; D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha